ArticleOncology and therapy2026

Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC): An Aggressive Disease Course and Limitations for Personalized Oncology.

Celine Oanæs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.